TIMI Score for STEMI Calculator

Score the TIMI Risk Score for STEMI from eight bedside variables — age, cardiac history, blood pressure, heart rate, Killip class, weight, ECG findings, and treatment delay — to estimate 30-day mortality risk.

Quick Facts

Score range
0 to 14 points
Sum of 8 weighted clinical variables assessed at presentation.
Source
Morrow et al., Circulation 2000
Derived and validated in the InTIME-II fibrinolysis-treated STEMI cohort.

Your Results

Calculated
TIMI risk score
-
Total points (0-14)
Est. 30-day mortality
-
Original fibrinolysis cohort
Risk category
-
Based on point total
Hemodynamic points
-
SBP + heart rate + Killip class

Ready

Enter presentation vitals and history, then calculate the TIMI STEMI risk score.

About the TIMI Risk Score for STEMI

The TIMI Risk Score for ST-elevation myocardial infarction (STEMI) is a bedside scoring system published by Morrow and colleagues in 2000, derived from the InTIME-II trial of fibrinolysis-treated STEMI patients. It combines eight variables available at presentation — age, cardiovascular history, systolic blood pressure, heart rate, Killip class, body weight, ECG findings, and treatment delay — into a single 0 to 14 point score that tracks with 30-day mortality risk.

How the score is built

Each variable contributes a fixed number of points once its threshold is met:

  • Age: 0 points under 65, 2 points for 65-74, 3 points for 75 and older.
  • History of diabetes, hypertension, or angina: 1 point if any is present.
  • Systolic blood pressure under 100 mmHg: 3 points.
  • Heart rate over 100 beats per minute: 2 points.
  • Killip class II-IV (rales, third heart sound, or cardiogenic shock) at presentation: 2 points.
  • Weight under 67 kg: 1 point.
  • Anterior ST elevation or new left bundle branch block: 1 point.
  • Time from symptom onset to treatment over 4 hours: 1 point.

Adding the eight components gives a total from 0 to 14. Because systolic blood pressure, heart rate, and Killip class describe hemodynamic status at presentation and carry the largest weights, the calculator also reports that three-item subtotal (out of 7 points) separately from the full score.

Interpreting the result

In the original derivation cohort, 30-day mortality rose steeply with the score: roughly 0.8% at a score of 0, climbing to the mid-single digits at scores of 3-4, into the teens and low twenties at scores of 5-7, and to roughly a quarter to a third of patients at scores of 8 or higher. A higher score summarizes risk factors already visible to the treating team — it does not by itself choose a treatment.

When to consult a professional

This tool performs the published TIMI STEMI arithmetic for education and reference. It is not a diagnosis and does not replace clinical judgment. Treatment decisions for a person experiencing a heart attack must be made immediately by emergency medical personnel, not derived from this calculator.

Frequently Asked Questions

What is the TIMI Risk Score for STEMI?
The TIMI Risk Score for STEMI is a bedside scoring system published by Morrow and colleagues in 2000 and derived from the InTIME-II trial of fibrinolysis-treated ST-elevation myocardial infarction patients. It combines eight variables available at presentation into a 0 to 14 point score that tracks with 30-day mortality risk.
How is the TIMI STEMI score calculated?
Points are added for age 65 or older (2 or 3 points), a history of diabetes, hypertension, or angina (1 point), systolic blood pressure under 100 mmHg (3 points), heart rate over 100 beats per minute (2 points), Killip class II-IV (2 points), weight under 67 kg (1 point), anterior ST elevation or new left bundle branch block (1 point), and time to treatment over 4 hours (1 point). The total ranges from 0 to 14.
What mortality does each TIMI STEMI score predict?
In the original derivation cohort, approximate 30-day mortality rose from about 0.8 percent at a score of 0 to roughly 4 to 7 percent at scores of 3 to 4, into the teens and low twenties at scores of 5 to 7, and to about 27 to 36 percent at scores of 8 or higher. These are population estimates from the derivation study, not an individual prognosis.